IRREVERSIBLE BINDING TO PROTEINS AFTER SINGLE AND REPEATED DAILY ORAL-ADMINISTRATION OF 4-(2,2-DIPHENYLETHYL) IMIDAZOLE (SC-46264) TO THE CYNOMOLGUS MONKEY
P. Jacqmin et al., IRREVERSIBLE BINDING TO PROTEINS AFTER SINGLE AND REPEATED DAILY ORAL-ADMINISTRATION OF 4-(2,2-DIPHENYLETHYL) IMIDAZOLE (SC-46264) TO THE CYNOMOLGUS MONKEY, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 299-307
SC-46264 is an antagonist of the alpha(2)-adrenergic receptor. Distrib
ution and excretion of [C-14]-SC-46264 were studied after single and r
epeated daily oral administrations to the Cynomolgus monkey at a 1.5 m
g/kg dose. After a single oral administration, more than 95% of the ad
ministered dose was recovered within 48 h in the urine (+/- 60%) and f
aeces (+/- 40%). Approximately 1.7% remained in the gastro-intestinal
(GI) tract and 2% in the animal body. However,the radioactivity remain
ing in the animal body decreased very slowly from 2 to 1% between 48 a
nd 144 h. An accumulation of very small amounts of radioactivity could
be suspected in the plasma, the liver, the thyroid, the adrenals and
the kidneys. In a 2 week daily oral administration of [C-14]-SC-46264,
the amount of total radioactivity remaining in the animal body 24, 48
and 216 h after the last administration was approximately 21, 11 and
5% of the daily administered dose, respectively. It confirmed the accu
mulation of [C-14]-SC-46264 related compound in the plasma, the liver,
the thyroid, the adrenals and the kidneys. The minimum plasma concent
rations of total radioactivity observed before each administration inc
reased during the treatment and apparently did not yet reach an equili
brium after 14 days. In these plasma samples obtained throughout the s
tudy, an increasing fraction of the total radioactivity could not be e
xtracted and was recovered with precipitable material. These observati
ons lead to the hypothesis of an irreversible binding of some material
to the proteins. To confirm that hypothesis based on the in vivo data
, a 1 h in vitro bioactivation of [C-14]-SC-46264 with rat liver micro
somes was conducted. It showed that 4.6% of the [C-14]-SC-46264 total
radioactivity used in the experiment could bind irreversibly to the pr
oteins. This binding was highly reduced by an inhibitor of the cytochr
ome mixed function oxidase or a free radical scavenger. This observati
on is consistent with a cytochrome P-450 dependent production of a [C-
14]-SC-46264 reactive intermediate that can covalently bind to protein
s during the phenyl hydroxylation observed with that compound.